Foreign body reaction after CyPass® Micro-Stent implantation: a case series

[1]  Eun Jung Lee,et al.  Ahmed implant coated with poly(2-methacryloyloxyethyl phosphorylcholine) inhibits foreign body reactions in rabbit eyes , 2021, PloS one.

[2]  S. Gedde,et al.  Safety profile of minimally invasive glaucoma surgery , 2020, Current opinion in ophthalmology.

[3]  G. Perdikakis,et al.  [Explantation of the CyPass implant in a case series of patients with corneal decompensation]. , 2020, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[4]  S. Fili,et al.  CyPass-Explantation bei einer Fallserie von Patienten mit Hornhautdekompensation , 2020, Der Ophthalmologe.

[5]  C. Auw-Haedrich,et al.  Chronic Granulomatous Inflammation after CyPass® Implantation , 2020, Ocular Oncology and Pathology.

[6]  A. Salimi,et al.  One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities , 2019, Ophthalmology and Therapy.

[7]  C. Hirneiss,et al.  A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I). , 2019, Ophthalmology. Glaucoma.

[8]  G. Reiss,et al.  Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: Five-Year Results from the COMPASS XT Study. , 2019, American journal of ophthalmology.

[9]  J. Lass,et al.  Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification With or Without CyPass Micro-Stent. , 2019, American journal of ophthalmology.

[10]  M. Kohlhaas,et al.  [One-year results after Cypass implantation]. , 2019, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[11]  H. Agostini.  Abstractband DOG 2019 , 2019, Der Ophthalmologe.

[12]  A. Mermoud,et al.  Chronic Intraocular Inflammation as a Risk Factor for XEN Gel Stent Occlusion: A Case of Microscopic Examination of a Fibrin-obstructed XEN Stent , 2018, Journal of glaucoma.

[13]  S. Fili,et al.  1-Jahres-Ergebnisse nach Cypass-Implantation , 2018, Der Ophthalmologe.

[14]  J. Lind,et al.  Review of the Xen Gel Stent and InnFocus MicroShunt , 2018, Current opinion in ophthalmology.

[15]  X. Navarro,et al.  Time course study of long-term biocompatibility and foreign body reaction to intraneural polyimide-based implants. , 2018, Journal of biomedical materials research. Part A.

[16]  P. Tengvall,et al.  Osseointegration and foreign body reaction: Titanium implants activate the immune system and suppress bone resorption during the first 4 weeks after implantation , 2018, Clinical implant dentistry and related research.

[17]  M. Kohlhaas,et al.  The STARflo glaucoma implant: preliminary 12 months results , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  E. Ansari.  An Update on Implants for Minimally Invasive Glaucoma Surgery (MIGS) , 2017, Ophthalmology and Therapy.

[19]  Prof. Dr. E. von Stebut.  Was ist ein Granulom? , 2017, Der Hautarzt.

[20]  J. Asai.  What is new in the histogenesis of granulomatous skin diseases? , 2017, The Journal of dermatology.

[21]  E. von Stebut.  [What is a granuloma?] , 2017, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[22]  T. Ianchulev,et al.  Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts. , 2016, Ophthalmology.

[23]  L. Katz,et al.  iStent® Trabecular Microbypass Stent: An Update , 2016, Journal of ophthalmology.

[24]  T. Ianchulev,et al.  Initial Clinical Experience With the CyPass Micro-Stent: Safety and Surgical Outcomes of a Novel Supraciliary Microstent , 2016, Journal of glaucoma.

[25]  Cseke István,et al.  Starflo glaucoma implant: early experience in Hungary , 2016, Romanian Journal of Ophthalmology.

[26]  T. Ianchulev,et al.  Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study. , 2015, American journal of ophthalmology.

[27]  J. Lapointe,et al.  Safety and biocompatibility of a novel self-expanding nitinol carotid stent with hybrid cell design in a porcine model of neointimal hyperplasia. , 2015, Kardiologia polska.

[28]  E. Margolina,et al.  [Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study]. , 2014, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[29]  S. Van Vlierberghe,et al.  Immunocompatibility evaluation of hydrogel-coated polyimide implants for applications in regenerative medicine. , 2014, Journal of biomedical materials research. Part A.

[30]  S. Ianchulev,et al.  Two-year Clinical Experience with the CyPass Micro-Stent: Safety and Surgical Outcomes of a Novel Supraciliary Micro-Stent , 2014, Klin Monatsbl Augenheilkd.

[31]  K. Jung,et al.  Foreign body reaction in glaucoma drainage implant surgery. , 2013, Investigative ophthalmology & visual science.

[32]  K. Jung,et al.  Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. , 2013, Ophthalmology.

[33]  B. Crestani,et al.  Granulomatous foreign‐body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report , 2012, The British journal of dermatology.

[34]  I. Ahmed,et al.  Micro-invasive glaucoma surgery: current perspectives and future directions , 2012, Current opinion in ophthalmology.

[35]  R. Velez-Montoya,et al.  Ocular biocompatibility of nitinol intraocular clips. , 2012, Investigative ophthalmology & visual science.

[36]  S. Kaufmann,et al.  For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection , 2011, Immunological reviews.

[37]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[38]  R. Ayyala,et al.  Anatomic and histopathologic findings following a failed ahmed glaucoma valve device. , 2001, Ophthalmic surgery and lasers.

[39]  C. Burgoyne,et al.  Biocompatibility response to modified Baerveldt glaucoma drains. , 1998, Journal of biomedical materials research.

[40]  R. Tripathi,et al.  Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye , 1991 .